Startseite
Impressum
Datenschutz
 
Volume 36, 4 November 2005 11/2005
 
  READERS' QUESTIONNAIRE
 

Evaluation: agreement and criticism

 
  SPOT ON
 

Manipulation of data in the PROactive-study suspected: Clinical benefit of pioglitazone (ACTOS) not proven

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Is there a benefit of trastuzumab (HERCEPTIN) in adjuvant therapy of breast cancer?
CATIE-study: do newer "atypical" neuroleptics possess real advantages?
Antibiotic prophylaxis for chemotherapy induced neutropenia

 
  IN BRIEF
 

Reducing intraocular pressure for prophylaxis and therapy of glaucoma
Conflicts of interest in clinical guidelines

 
  CURRENT ADR NETWORK REPORT
 

Hepatotoxicity of duloxetine (CYMBALTA, YENTREVE)

 
  SIDE EFFECTS
 

Malformation induced by the SSRI paroxetine (e.g. SEROXAT) during pregnancy
Atomoxetine (STRATTERA) promotes suicidality
Tibolone (LIVIELLA) and stroke

 
© arznei-telegramm 11/2005